JP2018517778A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018517778A5 JP2018517778A5 JP2018517499A JP2018517499A JP2018517778A5 JP 2018517778 A5 JP2018517778 A5 JP 2018517778A5 JP 2018517499 A JP2018517499 A JP 2018517499A JP 2018517499 A JP2018517499 A JP 2018517499A JP 2018517778 A5 JP2018517778 A5 JP 2018517778A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- tumor
- virus
- particles
- oncolytic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562182383P | 2015-06-19 | 2015-06-19 | |
| US62/182,383 | 2015-06-19 | ||
| PCT/IB2016/000993 WO2017037523A1 (en) | 2015-06-19 | 2016-06-17 | Compositions and methods for viral embolization |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018517778A JP2018517778A (ja) | 2018-07-05 |
| JP2018517778A5 true JP2018517778A5 (https=) | 2019-07-18 |
| JP6827467B2 JP6827467B2 (ja) | 2021-02-10 |
Family
ID=58186857
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018517499A Active JP6827467B2 (ja) | 2015-06-19 | 2016-06-17 | ウイルス塞栓術のための組成物および方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US10517910B2 (https=) |
| EP (1) | EP3310383B1 (https=) |
| JP (1) | JP6827467B2 (https=) |
| KR (1) | KR102735275B1 (https=) |
| CN (1) | CN108025056B (https=) |
| AU (1) | AU2016313969B2 (https=) |
| ES (1) | ES2795010T3 (https=) |
| WO (1) | WO2017037523A1 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4122492A1 (en) | 2015-02-25 | 2023-01-25 | Memorial Sloan Kettering Cancer Center | Use of inactivated nonreplicating modified vaccinia virus ankara (mva)as monoimmunotherapy or in combination with immune checkpoint blocking agents for solid tumors |
| KR20180006916A (ko) | 2015-04-17 | 2018-01-19 | 메모리얼 슬로안-케터링 캔서 센터 | 고형 종양에 대한 면역치료제로서 mva 또는 mva델타e3l의 용도 |
| CN108025056B (zh) | 2015-06-19 | 2022-01-14 | 新罗杰股份有限公司 | 用于病毒栓塞的组合物和方法 |
| JP7025339B2 (ja) | 2016-02-25 | 2022-02-24 | メモリアル スローン ケタリング キャンサー センター | 癌免疫療法のための、チミジンキナーゼの欠失を伴い、ヒトｆｌｔ３ｌまたはｇｍ－ｃｓｆの発現を伴うかまたは伴わない、複製可能な弱毒化ワクシニアウイルス |
| CN109152827B (zh) | 2016-02-25 | 2023-07-21 | 纪念斯隆凯特琳癌症中心 | 重组mva或表达人flt3l的mvaδe3l及其作为抗固体肿瘤的免疫治疗剂的用途 |
| KR102190326B1 (ko) * | 2016-07-21 | 2020-12-11 | 코오롱생명과학 주식회사 | 재조합 백시니아 바이러스 및 이의 용도 |
| EP3621646A4 (en) | 2017-05-12 | 2021-06-02 | Memorial Sloan Kettering Cancer Center | VACCINIA VIRUS MUTANTS FOR CANCER IMMUNOTHERAPY |
| CN109554353B (zh) * | 2017-09-26 | 2021-08-06 | 杭州康万达医药科技有限公司 | 分离的重组溶瘤痘病毒、药物组合物及其在治疗肿瘤和/或癌症的药物中的用途 |
| KR20190059421A (ko) * | 2017-11-23 | 2019-05-31 | 주식회사 바이오녹스 | 항암바이러스의 간동맥 투여를 이용한 간암 치료방법 |
| CA3106202A1 (en) | 2018-07-13 | 2020-01-16 | Arizona Board Of Regents On Behalf Of Arizona State University | Methods of treating cancer with tnf expressing myxoma virus |
| BR112021004692A2 (pt) | 2018-09-15 | 2021-06-08 | Memorial Sloan Kettering Cancer Center | poxvírus recombinantes para imunoterapia de câncer |
| US20240024393A1 (en) * | 2019-01-25 | 2024-01-25 | Virocure, Inc. | Pharmaceutical composition for preventing or treating cancer, comprising squirrel fibroma virus and reovirus |
| JP2022520220A (ja) | 2019-02-14 | 2022-03-29 | イグナイト イミュノセラピー インク | 組換えワクシニアウイルスおよびその使用方法 |
| MX2022002547A (es) * | 2019-09-02 | 2022-05-18 | Univ Arizona State | Una nueva plataforma de virus oncoliticos para tratar canceres con virus myxoma. |
| DE102020101197A1 (de) * | 2020-01-20 | 2021-07-22 | Charité - Universitätsmedizin Berlin | Medizinprodukt zur Arzneimittelabgabe mit verstärkter Wirkung |
| TW202217002A (zh) | 2020-07-13 | 2022-05-01 | 法商傳斯堅公司 | 免疫抑制之治療 |
| WO2023213763A1 (en) | 2022-05-02 | 2023-11-09 | Transgene | Poxvirus encoding a binding agent comprising an anti- pd-l1 sdab |
| WO2023213764A1 (en) | 2022-05-02 | 2023-11-09 | Transgene | Fusion polypeptide comprising an anti-pd-l1 sdab and a member of the tnfsf |
| CN116942888B (zh) * | 2023-09-11 | 2026-03-24 | 科睿驰（深圳）医疗科技发展有限公司 | 淀粉水凝胶栓塞微球及其制备方法 |
| WO2026041811A1 (en) | 2024-08-23 | 2026-02-26 | Transgene | Recombinant poxvirus and method for regulating the expression of toxic conditional gene products of said recombinant poxvirus in a producing cell |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5073627A (en) | 1989-08-22 | 1991-12-17 | Immunex Corporation | Fusion proteins comprising GM-CSF and IL-3 |
| JPH07509122A (ja) | 1992-04-08 | 1995-10-12 | ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ，アズ レプリゼンテッド バイ ザ セクレター，デパートメント オブ ヘルス アンド ヒューマン サービシーズ | 野生型麻疹ウイルス糖タンパク質：ワクチンおよびその検出方法 |
| FR2736358B1 (fr) | 1995-07-05 | 1997-09-26 | Agronomique Inst Nat Rech | Virus myxomateux recombinant |
| AU8877098A (en) | 1997-09-05 | 1999-03-29 | Nycomed Imaging As | Polymer particles made of polyvinyl alcohol and comprising contrast agent for chemoembolization |
| FR2784580B1 (fr) * | 1998-10-16 | 2004-06-25 | Biosepra Inc | Microspheres de polyvinyl-alcool et procedes de fabrication de celles-ci |
| KR100872884B1 (ko) * | 2000-03-24 | 2008-12-10 | 바이오스피어 메디칼 인코포레이티드 | 능동 색전화용 미소구 |
| JP2004510724A (ja) * | 2000-10-06 | 2004-04-08 | ヤゴテック アーゲー | 分子量の低下した澱粉からなる微粒子中に埋め込まれた免疫学的活性物質を含むワクチン組成物 |
| DE03722131T1 (de) | 2002-05-09 | 2005-09-15 | Oncolytics Biotech, Inc., Calgary | Methode zur schmerzbekämpfung mit onkolytischen viren |
| EP2269619A1 (en) * | 2002-08-12 | 2011-01-05 | Jennerex Biotherapeutics ULC | Methods and compositions concerning poxviruses and cancer |
| KR101772375B1 (ko) * | 2005-09-07 | 2017-08-29 | 신라젠(주) | Ｇｍ-ｃｓｆ를 발현하는 폭스바이러스를 사용한 전이성 및/또는 전신 파종성 암의 전신 치료법 |
| US8980246B2 (en) * | 2005-09-07 | 2015-03-17 | Sillajen Biotherapeutics, Inc. | Oncolytic vaccinia virus cancer therapy |
| JPWO2008105504A1 (ja) * | 2007-03-01 | 2010-06-03 | コスメディ製薬株式会社 | 経皮免疫製剤、その製造方法及びそれを用いた経皮免疫方法 |
| KR20080084528A (ko) * | 2007-03-15 | 2008-09-19 | 제네렉스 바이오테라퓨틱스 인크. | 종양살상형 백시니아 바이러스 암 치료 |
| BR112012005774B8 (pt) * | 2009-09-14 | 2023-02-14 | Jennerex Inc | uso de um inibidor de quinase antiangiogênico no tratamento de câncer |
| WO2011135734A1 (ja) * | 2010-04-28 | 2011-11-03 | 株式会社アルファ・ナノ・メディカ | ウイルスの複合体、それを含有する治療薬及び治療方法 |
| US9724421B2 (en) * | 2010-11-29 | 2017-08-08 | Centre Hospitalier Universitaire Vaudois | Chemoembolization composition comprising anti-angiogenic agents |
| KR101942237B1 (ko) * | 2011-01-04 | 2019-01-25 | 신라젠(주) | 종양 항원에 대한 항체의 생산 및 종양용해 우두 바이러스의 투여에 의한 종양 특이적 보체 의존적 세포독성의 생산 |
| EP2739293B1 (en) | 2011-08-05 | 2020-06-10 | SillaJen Biotherapeutics, Inc. | Methods and compositions for production of vaccina virus |
| WO2014031693A1 (en) * | 2012-08-20 | 2014-02-27 | Genelux Corporation | Compositions containing protein polymers and vaccinia virus, and methods of use thereof |
| US20140194370A1 (en) * | 2013-01-08 | 2014-07-10 | University Of Utah Research Foundation | Silk-elastin like protein polymers for embolization and chemoembolization to treat cancer |
| CN108025056B (zh) | 2015-06-19 | 2022-01-14 | 新罗杰股份有限公司 | 用于病毒栓塞的组合物和方法 |
| HK1255192A1 (zh) * | 2015-09-08 | 2019-08-09 | Sillajen, Inc. | 表达细胞因子和羧酸酯酶的修饰的溶瘤痘苗病毒及其使用方法 |
-
2016
- 2016-06-17 CN CN201680048316.5A patent/CN108025056B/zh active Active
- 2016-06-17 KR KR1020187001688A patent/KR102735275B1/ko active Active
- 2016-06-17 ES ES16840890T patent/ES2795010T3/es active Active
- 2016-06-17 WO PCT/IB2016/000993 patent/WO2017037523A1/en not_active Ceased
- 2016-06-17 JP JP2018517499A patent/JP6827467B2/ja active Active
- 2016-06-17 AU AU2016313969A patent/AU2016313969B2/en not_active Ceased
- 2016-06-17 US US15/738,034 patent/US10517910B2/en active Active
- 2016-06-17 EP EP16840890.4A patent/EP3310383B1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018517778A5 (https=) | ||
| CN108025056B (zh) | 用于病毒栓塞的组合物和方法 | |
| JP6907283B2 (ja) | ポリマー粒子 | |
| ES2551164T3 (es) | Microesferas para embolización activa | |
| EP2861257B1 (en) | Polymeric treatment compositions | |
| Ito et al. | Imatinib attenuates severe mouse dystrophy and inhibits proliferation and fibrosis-marker expression in muscle mesenchymal progenitors | |
| EP1687032A1 (en) | Therapeutic regimen for treating cancer | |
| JP2020517272A5 (https=) | ||
| JP2014523236A5 (https=) | ||
| TW201718016A (zh) | 聚合物及微球體 | |
| JP2025108532A (ja) | 非分解性の塞栓ミクロスフェア | |
| Kong et al. | Calcium carbonate microparticles used as a gene vector for delivering p53 gene into cancer cells | |
| Zhang et al. | Polyethyleneimine-coated Fe3O4 nanoparticles for efficient siRNA delivery to human mesenchymal stem cells derived from different tissues | |
| JP7793513B2 (ja) | 非分解性放射線不透過性塞栓ミクロスフェア | |
| Hu et al. | The effects of marsupialization on bone regeneration adjacent to keratocystic odontogenic tumors, and the mechanisms involved | |
| KR102075823B1 (ko) | 항암치료 및 유전자 치료용 나노입자를 포함하는 간동맥 화학색전술용 조성물 | |
| WO2017156102A1 (en) | Methods and compositions for dental tissue repair and/or regeneration | |
| CN105131161B (zh) | 用于骨水泥的自显影聚甲基丙烯酸酯及自显影骨水泥的制备方法 | |
| Taniyama et al. | Systemic malacoplakia in a breeding pig | |
| Sola et al. | Multifocal angiomyolipoma in a patient with tuberous sclerosis | |
| Patel et al. | Pharmaceuticals for intra-arterial therapy | |
| CA2990133C (en) | Compositions and methods for viral embolization | |
| TWI733564B (zh) | 骨水泥組成物 | |
| DE102009043551B4 (de) | Implantatmaterial sowie Verfahren zu dessen Herstellung | |
| CN121588268A (zh) | 一种可降解显影栓塞微球及其制备方法和应用 |